Stocks and Investing Stocks and Investing
Mon, July 22, 2024

Edward Nash Maintained (VRNA) at Strong Buy with Increased Target to $37 on, Jul 22nd, 2024


Published on 2024-10-28 12:38:47 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $35 to $37 on, Jul 22nd, 2024.

Edward has made no other calls on VRNA in the last 4 months.



There are 3 other peers that have a rating on VRNA. Out of the 3 peers that are also analyzing VRNA, 0 agree with Edward's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Edward


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $36 on, Monday, July 1st, 2024
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $38 on, Friday, June 28th, 2024
  • Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Increased Target to $36 on, Tuesday, April 16th, 2024

Contributing Sources